The use of prostate stem cell antigen–targeted CAR T-cell therapy was well tolerated and produced evidence of anticancer effects in patients with metastatic castration-resistant prostate cancer. onclive.com/view/psca-targe...
CART trial, just FYI: The use of... - Advanced Prostate...
CART trial, just FYI
Written by
Bkraus1
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
FYI: Be careful when considering RX
Dirty Little Secret That Prostate Biopsies Really Do Spread Prostate Cancer Cells\\" which I have...
City of Hope CART Treatment for NEPC
CART therapy
https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.cityofhope.org%
New radiopharmaceutical (Ac-225-PSMA-617) has high rates of remission in early trials
emitter that targets prostate cancer cells. Lu-177-PSMA-617 is a beta particle emitter that targets...
I'm new here and just finished clinical trial.
Promising phase 1 trial…
Is anyone familiar with the GUN trial?
Enzalutamide Product info, FYI
